BIO KEY INTERNATIONAL INC short interest in 2018
In 2018, BIO KEY INTERNATIONAL INC's disclosed short interest ran from 0.11% of shares outstanding on 12 Jan 2018 to 0.33% on 31 Dec 2018, a change of +0.22 percentage points. The year's high was 0.65% on 15 Aug 2018 and its low 0.11% on 12 Jan 2018, averaging 0.38% across 20 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 6.15 days on 14 Dec 2018. Full history: BIO KEY INTERNATIONAL INC.
Cite this page
By year: 2018 · 2019 · 2020 · 2021 · 2022 · 2023 · 2024 · 2025
2018 in figures
- Start of year
- 0.11% (12 Jan 2018)
- End of year
- 0.33% (31 Dec 2018)
- Change
- +0.22 pp
- High
- 0.65% (15 Aug 2018)
- Low
- 0.11% (12 Jan 2018)
- Average
- 0.38%
- Highest days to cover
- 6.15 (14 Dec 2018)
- SEC filings marked
- 9
Every report in 2018
| Settlement | Short interest | Days to cover | Filings since previous |
|---|---|---|---|
| 12 Jan 2018 | 0.11% | 1.00 | |
| 29 Mar 2018 | 0.31% | 1.00 | results (8-K), results (8-K) |
| 13 Apr 2018 | 0.40% | 1.00 | 10-K filed |
| 30 Apr 2018 | 0.42% | 1.75 | |
| 15 May 2018 | 0.32% | 1.17 | 10-Q filed |
| 31 May 2018 | 0.36% | 2.03 | results (8-K) |
| 15 Jun 2018 | 0.24% | 1.00 | |
| 29 Jun 2018 | 0.38% | 1.00 | |
| 13 Jul 2018 | 0.32% | 1.10 | |
| 31 Jul 2018 | 0.61% | 1.16 | |
| 15 Aug 2018 | 0.65% | 3.87 | 10-Q filed, results (8-K) |
| 31 Aug 2018 | 0.42% | 3.45 | |
| 14 Sep 2018 | 0.40% | 4.52 | |
| 28 Sep 2018 | 0.41% | 1.13 | |
| 15 Oct 2018 | 0.40% | 5.96 | |
| 31 Oct 2018 | 0.32% | 1.76 | |
| 15 Nov 2018 | 0.37% | 1.79 | 10-Q filed, results (8-K) |
| 30 Nov 2018 | 0.42% | 3.80 | |
| 14 Dec 2018 | 0.35% | 6.15 | |
| 31 Dec 2018 | 0.33% | 1.79 |
See also: BIO KEY INTERNATIONAL INC's full history · most shorted US stocks of 2018 · today's US league.
About this data
US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.